Jelena Kornej1, Gerhard Hindricks2, Amitava Banerjee3, Arash Arya2, Philipp Sommer2, Sascha Rolf2, Daniela Husser2, Gregory Y H Lip3, Andreas Bollmann2. 1. Department of Electrophysiology, Heart Center, University of Leipzig, Leipzig, Germany Centre for Cardiovascular Sciences, University of Birmingham, City Hospital, Birmingham, UK. 2. Department of Electrophysiology, Heart Center, University of Leipzig, Leipzig, Germany. 3. Centre for Cardiovascular Sciences, University of Birmingham, City Hospital, Birmingham, UK.
Abstract
BACKGROUND: Renal impairment is associated with poor prognosis in the setting of atrial fibrillation (AF). While AF catheter ablation is an effective treatment modality for AF burden reduction and improvement of symptoms, changes in renal function after catheter ablation and their association with rhythm outcome have not been studied in a large contemporary AF ablation cohort. OBJECTIVE: To determine the association between CHADS2 and CHA2DS2-VASc scores and arrhythmia recurrences with changes in renal function following AF catheter ablation. METHODS: Estimated glomerular filtration rate (eGFR) was estimated using the Chronic Kidney Disease Epidemiology Collaboration equation at baseline and during follow-up in 783 patients undergoing de novo AF catheter ablation. Complete rhythm follow-up was achieved in 626 patients (80%) using serial 7-day Holter ECG. RESULTS: The study population (n=783, 61±10 years, 64% men, 57% paroxysmal AF) was followed up at median 20 (IQR 12-27) months. Baseline eGFR correlated with CHADS2 (β=-0.258, p<0.001) and CHA2DS2-VASc scores (β=-0.434, p<0.001). On multivariable analyses, eGFR changes were associated with AF recurrences (B=-0.136, p=0.014), CHADS2 (B=-0.062, p=0.035) and CHA2DS2-VASc scores (B=-0.057, p=0.003). CONCLUSIONS: In patients after AF catheter ablation, eGFR changes during mid-term follow-up are associated with AF recurrences, CHADS2 and CHA2DS2-VASc scores. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
BACKGROUND: Renal impairment is associated with poor prognosis in the setting of atrial fibrillation (AF). While AF catheter ablation is an effective treatment modality for AF burden reduction and improvement of symptoms, changes in renal function after catheter ablation and their association with rhythm outcome have not been studied in a large contemporary AF ablation cohort. OBJECTIVE: To determine the association between CHADS2 and CHA2DS2-VASc scores and arrhythmia recurrences with changes in renal function following AF catheter ablation. METHODS: Estimated glomerular filtration rate (eGFR) was estimated using the Chronic Kidney Disease Epidemiology Collaboration equation at baseline and during follow-up in 783 patients undergoing de novo AF catheter ablation. Complete rhythm follow-up was achieved in 626 patients (80%) using serial 7-day Holter ECG. RESULTS: The study population (n=783, 61±10 years, 64% men, 57% paroxysmal AF) was followed up at median 20 (IQR 12-27) months. Baseline eGFR correlated with CHADS2 (β=-0.258, p<0.001) and CHA2DS2-VASc scores (β=-0.434, p<0.001). On multivariable analyses, eGFR changes were associated with AF recurrences (B=-0.136, p=0.014), CHADS2 (B=-0.062, p=0.035) and CHA2DS2-VASc scores (B=-0.057, p=0.003). CONCLUSIONS: In patients after AF catheter ablation, eGFR changes during mid-term follow-up are associated with AF recurrences, CHADS2 and CHA2DS2-VASc scores. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Authors: D Mastronicola; E Arcuri; M Arese; A Bacchi; S Mercadante; P Cardelli; G Citro; P Sarti Journal: Cell Mol Life Sci Date: 2004-12 Impact factor: 9.261
Authors: Jelena Kornej; Gerhard Hindricks; Arash Arya; Philipp Sommer; Daniela Husser; Andreas Bollmann Journal: PLoS One Date: 2017-01-13 Impact factor: 3.240
Authors: Yoav Y Pikkel; Daniel Krebs; Vadim Igal; Adi Sharabi-Nov; Irena Epstein; Joseph Pikkel Journal: J Ophthalmol Date: 2018-01-31 Impact factor: 1.909
Authors: Katja Schumacher; Petra Büttner; Nikolaos Dagres; Philipp Sommer; Borislav Dinov; Gerhard Hindricks; Andreas Bollmann; Jelena Kornej Journal: PLoS One Date: 2018-11-05 Impact factor: 3.240
Authors: Giuseppe Boriani; Cécile Laroche; Igor Diemberger; Mircea Ioachim Popescu; Lars Hvilsted Rasmussen; Lucian Petrescu; Harry J G M Crijns; Luigi Tavazzi; Aldo P Maggioni; Gregory Y H Lip Journal: Sci Rep Date: 2016-07-28 Impact factor: 4.379